Anti-LICH/ LIPA/ CESD functional antibody

Anti-LICH/ LIPA/ CESD functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to LIPA/LIPA products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T24373-Ab-1/ GM-Tg-hg-T24373-Ab-2Anti-Human LIPA monoclonal antibodyHuman
GM-Tg-rg-T24373-Ab-1/ GM-Tg-rg-T24373-Ab-2Anti-Rat LIPA monoclonal antibodyRat
GM-Tg-mg-T24373-Ab-1/ GM-Tg-mg-T24373-Ab-2Anti-Mouse LIPA monoclonal antibodyMouse
GM-Tg-cynog-T24373-Ab-1/ GM-Tg-cynog-T24373-Ab-2Anti-Cynomolgus/ Rhesus macaque LIPA monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T24373-Ab-1/ GM-Tg-felg-T24373-Ab-2Anti-Feline LIPA monoclonal antibodyFeline
GM-Tg-cang-T24373-Ab-1/ GM-Tg-cang-T24373-Ab-2Anti-Canine LIPA monoclonal antibodyCanine
GM-Tg-bovg-T24373-Ab-1/ GM-Tg-bovg-T24373-Ab-2Anti-Bovine LIPA monoclonal antibodyBovine
GM-Tg-equg-T24373-Ab-1/ GM-Tg-equg-T24373-Ab-2Anti-Equine LIPA monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T24373-Ab-1/ GM-Tg-hg-T24373-Ab-2; GM-Tg-rg-T24373-Ab-1/ GM-Tg-rg-T24373-Ab-2;
GM-Tg-mg-T24373-Ab-1/ GM-Tg-mg-T24373-Ab-2; GM-Tg-cynog-T24373-Ab-1/ GM-Tg-cynog-T24373-Ab-2;
GM-Tg-felg-T24373-Ab-1/ GM-Tg-felg-T24373-Ab-2; GM-Tg-cang-T24373-Ab-1/ GM-Tg-cang-T24373-Ab-2;
GM-Tg-bovg-T24373-Ab-1/ GM-Tg-bovg-T24373-Ab-2; GM-Tg-equg-T24373-Ab-1/ GM-Tg-equg-T24373-Ab-2
Products NameAnti-LIPA monoclonal antibody
Formatmab
Target NameLIPA
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LIPA benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T24373-Ag-1Recombinant multi-species LICH/ LIPA/ CESD protein
    ORF Viral VectorvGMLP002961human LIPA Lentivirus particle
    ORF Viral VectorpGMLP002961human LIPA Lentivirus plasmid
    ORF Viral VectorpGMLPm004929mouse Lipa Lentivirus plasmid
    ORF Viral VectorvGMLPm004929mouse Lipa Lentivirus particle


    Target information

    Target IDGM-T24373
    Target NameLIPA
    Gene ID3988,16889,25055,695240,100856363,101094134,100125267,100071626
    Gene Symbol and SynonymsCESD,Chole,Chole2,LAL,Lip-1,Lip1,LIPA
    Uniprot AccessionP38571,Q64194
    Uniprot Entry NameLICH_HUMAN,LICH_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target
    DiseaseCancer
    Gene EnsemblENSG00000107798
    Target ClassificationTumor-associated antigen (TAA)

    The target: LIPA, gene name: LIPA, also named as CESD, LAL. This gene encodes lipase A, the lysosomal acid lipase (also known as cholesterol ester hydrolase). This enzyme functions in the lysosome to catalyze the hydrolysis of cholesteryl esters and triglycerides. Mutations in this gene can result in Wolman disease and cholesteryl ester storage disease. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.